Safety and immunologic correlates of Melanoma GVAX, a GM-CSF secreting allogeneic melanoma cell vaccine administered in the adjuvant setting-Reference-Cited by-同舟云学术

Safety and immunologic correlates of Melanoma GVAX, a GM-CSF secreting allogeneic melanoma cell vaccine administered in the adjuvant setting

Published:2015-07-05 Issue:1 Volume:13 Page:
ISSN:1479-5876
Container-title:Journal of Translational Medicine
language:en
Short-container-title:J Transl Med

Author:

Lipson Evan J,Sharfman William H,Chen Shuming,McMiller Tracee L,Pritchard Theresa S,Salas January T,Sartorius-Mergenthaler Susan,Freed Irwin,Ravi Sowmya,Wang Hao,Luber Brandon,Sproul Janice Davis,Taube Janis M,Pardoll Drew M,Topalian Suzanne L

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

http://link.springer.com/content/pdf/10.1186/s12967-015-0572-3

Reference60 articles.

1. Kirkwood JM, Strawderman MH, Ernstoff MS, Smith TJ, Borden EC, Blum RH (1996) Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684. J Clin Oncol 14:7–17

2. Kirkwood JM, Ibrahim JG, Sondak VK, Richards J, Flaherty LE, Ernstoff MS et al (2000) High- and low-dose interferon alfa-2b in high-risk melanoma: first analysis of intergroup trial E1690/S9111/C9190. J Clin Oncol 18:2444–2458

3. Kirkwood JM, Ibrahim JG, Sosman JA, Sondak VK, Agarwala SS, Ernstoff MS et al (2001) High-dose interferon alfa-2b significantly prolongs relapse-free and overall survival compared with the GM2-KLH/QS-21 vaccine in patients with resected stage IIB-III melanoma: results of intergroup trial E1694/S9512/C509801. J Clin Oncol 19:2370–2380

4. Balch CM, Soong SJ, Atkins MB, Buzaid AC, Cascinelli N, Coit DG et al (2004) An evidence-based staging system for cutaneous melanoma. CA Cancer J Clin 54:131–149

5. Topalian SL, Weiner GJ, Pardoll DM (2011) Cancer immunotherapy comes of age. J Clin Oncol 29:4828–4836

Cited by 81 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Road Ahead in Pancreatic Cancer: Emerging Trends and Therapeutic Prospects;Biomedicines;2024-09-02

2. Generation of the therapeutic monoclonal antibody NEO-201, derived from a cancer vaccine, which targets human malignancies and immune suppressor cells;Expert Review of Vaccines;2024-09

3. KLF4 suppresses anticancer effects of brusatol via transcriptional upregulating NCK2 expression in melanoma;Biochemical Pharmacology;2024-05

4. Radiofrequency Combined with Intratumoral Immunotherapy: Preclinical Results and Safety in Metastatic Colorectal Carcinoma;Pharmaceutics;2024-02-23

5. Pathologic fractures of the humerus during adjuvant pembrolizumab in patients with renal cell carcinoma after radical nephrectomy: A case report;International Journal of Surgery Case Reports;2024-02